Merck & Co., Inc.

United States of America

Back to Profile

1-100 of 6,216 for Merck & Co., Inc. and 30 subsidiaries Sort by
Query
Aggregations
IP Type
        Patent 3,840
        Trademark 2,376
Jurisdiction
        World 3,553
        United States 1,221
        Canada 1,078
        Europe 364
Owner / Subsidiary
Merck Sharp & Dohme Corp. 2,183
Intervet International B.V. 1,337
Merck Sharp & Dohme B.V. 936
Intervet Inc. 930
N.V. Organon 525
See more
Date
New (last 4 weeks) 26
2026 August (MTD) 34
2026 July 20
2026 June 26
2026 May 8
See more
IPC Class
A61K 39/00 - Medicinal preparations containing antigens or antibodies 287
A61K 39/12 - Viral antigens 215
A61P 35/00 - Antineoplastic agents 212
A61K 39/395 - AntibodiesImmunoglobulinsImmune serum, e.g. antilymphocytic serum 178
C07K 16/28 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants 175
See more
NICE Class
05 - Pharmaceutical, veterinary and sanitary products 2,085
44 - Medical, veterinary, hygienic and cosmetic services; agriculture, horticulture and forestry services 213
10 - Medical apparatus and instruments 158
42 - Scientific, technological and industrial services, research and design 129
09 - Scientific and electric apparatus and instruments 123
See more
Status
Pending 546
Registered / In Force 5,670
  1     2     3     ...     63        Next Page

1.

TULWAIV

      
Application Number 1934732
Status Registered
Filing Date 2026-07-01
Registration Date 2026-07-01
Owner Merck Sharp & Dohme B.V. (Netherlands)
NICE Classes  ? 05 - Pharmaceutical, veterinary and sanitary products

Goods & Services

Pharmaceutical preparations; human vaccine preparations.

2.

VERTIQTA

      
Application Number 1935646
Status Registered
Filing Date 2026-07-21
Registration Date 2026-07-21
Owner Intervet International B.V. (Netherlands)
NICE Classes  ? 05 - Pharmaceutical, veterinary and sanitary products

Goods & Services

Parasiticides for veterinary use.

3.

TYKANVIS

      
Application Number 1935573
Status Registered
Filing Date 2026-07-31
Registration Date 2026-07-31
Owner Merck Sharp & Dohme B.V. (Netherlands)
NICE Classes  ? 05 - Pharmaceutical, veterinary and sanitary products

Goods & Services

Pharmaceutical preparations for use in oncology.

4.

TILVIGHT

      
Application Number 1934731
Status Registered
Filing Date 2026-07-01
Registration Date 2026-07-01
Owner Merck Sharp & Dohme B.V. (Netherlands)
NICE Classes  ? 05 - Pharmaceutical, veterinary and sanitary products

Goods & Services

Pharmaceutical preparations; human vaccine preparations.

5.

PRELTO

      
Application Number 1935649
Status Registered
Filing Date 2026-07-21
Registration Date 2026-07-21
Owner Intervet International B.V. (Netherlands)
NICE Classes  ? 05 - Pharmaceutical, veterinary and sanitary products

Goods & Services

Parasiticides for veterinary use.

6.

BOSTUKADE

      
Application Number 1935572
Status Registered
Filing Date 2026-07-31
Registration Date 2026-07-31
Owner Merck Sharp & Dohme B.V. (Netherlands)
NICE Classes  ? 05 - Pharmaceutical, veterinary and sanitary products

Goods & Services

Pharmaceutical preparations for use in oncology.

7.

Miscellaneous Design

      
Application Number 1934005
Status Registered
Filing Date 2026-05-27
Registration Date 2026-05-27
Owner Intervet International B.V. (Netherlands)
NICE Classes  ? 05 - Pharmaceutical, veterinary and sanitary products

Goods & Services

Veterinary vaccines for companion animals.

8.

DNA VACCINE FOR FISH AGAINST SALMONID ALPHAVIRUS

      
Application Number 19160357
Status Pending
Filing Date 2024-02-29
First Publication Date 2026-08-27
Owner INTERVET INC. (USA)
Inventor
  • Villoing, Stephane
  • Langereis, Martijn Alexander
  • Vossen, Christiaan

Abstract

Salmonid alphavirus (SAV) is an important pathogen affecting the aquaculture of Salmonid fish. Vaccines based on DNA plasmids expressing a SAV antigen have been described. However these are difficult to prepare at large scale and at the desired quality level. Also, they are commonly administered at relatively high amounts of plasmid per animal dose. This makes such DNA vaccines less affordable for this market. The invention discloses an improved plasmid that allows effective use as a DNA vaccine against SAV, but at a much reduced amount of DNA per dose. The plasmid contains a gene encoding a bacterial enzyme: Fab.

IPC Classes  ?

  • A61K 39/12 - Viral antigens
  • A61K 39/00 - Medicinal preparations containing antigens or antibodies
  • A61P 31/14 - Antivirals for RNA viruses
  • C07K 14/005 - Peptides having more than 20 amino acidsGastrinsSomatostatinsMelanotropinsDerivatives thereof from viruses
  • C12N 7/00 - Viruses, e.g. bacteriophagesCompositions thereofPreparation or purification thereof
  • C12N 9/02 - Oxidoreductases (1.), e.g. luciferase
  • C12N 15/85 - Vectors or expression systems specially adapted for eukaryotic hosts for animal cells

9.

CANINIZED ANTIBODIES TO CANINE INTERLEUKIN-31 RECEPTOR ALPHA

      
Application Number 19542452
Status Pending
Filing Date 2026-02-17
First Publication Date 2026-08-27
Owner INTERVET INC. (USA)
Inventor
  • Morsey, Mohamad
  • Zhang, Yuanzheng
  • Saha, Anasuya

Abstract

The present invention provides caninized rat antibodies to canine IL-31 receptor alpha that have a high binding affinity for canine IL-31 receptor alpha, and that can block the binding of canine IL-31 to canine IL-31 receptor alpha. The present invention further provides the use of the antibodies for the treatment of atopic dermatitis in dogs.

IPC Classes  ?

  • C07K 16/28 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
  • A61P 17/04 - Antipruritics
  • C12N 15/63 - Introduction of foreign genetic material using vectorsVectorsUse of hosts thereforRegulation of expression

10.

CONTROLLED RELEASE PDE10A FORMULATIONS

      
Application Number 19163501
Status Pending
Filing Date 2024-03-25
First Publication Date 2026-08-27
Owner
  • Merck Sharp & Dohme LLC (USA)
  • Merck Sharp & Dohme (UK) Limited (United Kingdom)
Inventor
  • Dinunzio, James C.
  • Harris, David
  • Kumar, Maria Sharlini
  • Pollitt, Michael John
  • Radojevic, Jovana
  • Terife, Graciela

Abstract

The present disclosure relates generally to treatment of central nervous system disorders associated with phosphodiesterase 10A (PDE10A) such as schizophrenia, bipolar disease, and Alzheimer's disease, as therapeutics for neurological and psychiatric disorders. This disclosure provides controlled-release formulations of 2-methyl-N-((5-methyl-1,3,4-thiadiazol-2-yl)methyl)-6-(((1S,2S)-2-(5-methylpyridin-2-yl)cyclopropyl)methoxy)pyrimidin-4-amine (Compound A) and their use in the treatment of schizophrenia and other psychiatric disorders that improves the tolerability profile.

IPC Classes  ?

  • A61K 31/506 - PyrimidinesHydrogenated pyrimidines, e.g. trimethoprim not condensed and containing further heterocyclic rings
  • A61K 9/20 - Pills, lozenges or tablets

11.

GILKANRI

      
Serial Number 50049205
Status Pending
Filing Date 2026-08-13
Owner Merck Sharp & Dohme B.V. (Netherlands)
NICE Classes  ? 05 - Pharmaceutical, veterinary and sanitary products

Goods & Services

Pharmaceutical preparations for the treatment and prevention of bone, cardiovascular, central nervous system, dermatological, endocrine, hematological, hepatological, immunological, gastrointestinal, genitourinary, gynecological, metabolic, musculoskeletal, nephrological, neurological, oncological, ophthalmic, retinal, psychiatric, pulmonary, renal, respiratory, and urological diseases and disorders; Pharmaceutical preparations for the treatment and prevention of autoimmune diseases, asthma, cancer and tumors, chronic cough, diabetes, hypertension, insomnia, intestinal infections, skin disorders, and urinary incontinence; Inhalers filled with pharmaceutical preparations for the treatment of cardiovascular diseases and disorders; Antibacterial pharmaceuticals; Antibiotics; Antifungal preparations; Anti-infectives; Anti-inflammatories; Antiparasitics; Antivirals; Human vaccine preparations

12.

GILKRANSI

      
Serial Number 50049208
Status Pending
Filing Date 2026-08-13
Owner Merck Sharp & Dohme B.V. (Netherlands)
NICE Classes  ? 05 - Pharmaceutical, veterinary and sanitary products

Goods & Services

Pharmaceutical preparations for the treatment and prevention of bone, cardiovascular, central nervous system, dermatological, endocrine, hematological, hepatological, immunological, gastrointestinal, genitourinary, gynecological, metabolic, musculoskeletal, nephrological, neurological, oncological, ophthalmic, retinal, psychiatric, pulmonary, renal, respiratory, and urological diseases and disorders; Pharmaceutical preparations for the treatment and prevention of autoimmune diseases, asthma, cancer and tumors, chronic cough, diabetes, hypertension, insomnia, intestinal infections, skin disorders, and urinary incontinence; Inhalers filled with pharmaceutical preparations for the treatment of cardiovascular diseases and disorders; Antibacterial pharmaceuticals; Antibiotics; Antifungal preparations; Anti-infectives; Anti-inflammatories; Antiparasitics; Antivirals; Human vaccine preparations

13.

KANRASLI

      
Serial Number 50049212
Status Pending
Filing Date 2026-08-13
Owner Merck Sharp & Dohme B.V. (Netherlands)
NICE Classes  ? 05 - Pharmaceutical, veterinary and sanitary products

Goods & Services

Pharmaceutical preparations for the treatment and prevention of bone, cardiovascular, central nervous system, dermatological, endocrine, hematological, hepatological, immunological, gastrointestinal, genitourinary, gynecological, metabolic, musculoskeletal, nephrological, neurological, oncological, ophthalmic, retinal, psychiatric, pulmonary, renal, respiratory, and urological diseases and disorders; Pharmaceutical preparations for the treatment and prevention of autoimmune diseases, asthma, cancer and tumors, chronic cough, diabetes, hypertension, insomnia, intestinal infections, skin disorders, and urinary incontinence; Inhalers filled with pharmaceutical preparations for the treatment of cardiovascular diseases and disorders; Antibacterial pharmaceuticals; Antibiotics; Antifungal preparations; Anti-infectives; Anti-inflammatories; Antiparasitics; Antivirals; Human vaccine preparations

14.

KASBYLVI

      
Serial Number 50049215
Status Pending
Filing Date 2026-08-13
Owner Merck Sharp & Dohme B.V. (Netherlands)
NICE Classes  ? 05 - Pharmaceutical, veterinary and sanitary products

Goods & Services

Pharmaceutical preparations for the treatment and prevention of bone, cardiovascular, central nervous system, dermatological, endocrine, hematological, hepatological, immunological, gastrointestinal, genitourinary, gynecological, metabolic, musculoskeletal, nephrological, neurological, oncological, ophthalmic, retinal, psychiatric, pulmonary, renal, respiratory, and urological diseases and disorders; Pharmaceutical preparations for the treatment and prevention of autoimmune diseases, asthma, cancer and tumors, chronic cough, diabetes, hypertension, insomnia, intestinal infections, skin disorders, and urinary incontinence; Inhalers filled with pharmaceutical preparations for the treatment of cardiovascular diseases and disorders; Antibacterial pharmaceuticals; Antibiotics; Antifungal preparations; Anti-infectives; Anti-inflammatories; Antiparasitics; Antivirals; Human vaccine preparations

15.

GILKRASVY

      
Serial Number 50049224
Status Pending
Filing Date 2026-08-13
Owner Merck Sharp & Dohme B.V. (Netherlands)
NICE Classes  ? 05 - Pharmaceutical, veterinary and sanitary products

Goods & Services

Pharmaceutical preparations for the treatment and prevention of bone, cardiovascular, central nervous system, dermatological, endocrine, hematological, hepatological, immunological, gastrointestinal, genitourinary, gynecological, metabolic, musculoskeletal, nephrological, neurological, oncological, ophthalmic, retinal, psychiatric, pulmonary, renal, respiratory, and urological diseases and disorders; Pharmaceutical preparations for the treatment and prevention of autoimmune diseases, asthma, cancer and tumors, chronic cough, diabetes, hypertension, insomnia, intestinal infections, skin disorders, and urinary incontinence; Inhalers filled with pharmaceutical preparations for the treatment of cardiovascular diseases and disorders; Antibacterial pharmaceuticals; Antibiotics; Antifungal preparations; Anti-infectives; Anti-inflammatories; Antiparasitics; Antivirals; Human vaccine preparations

16.

KAZBYLVI

      
Serial Number 50049234
Status Pending
Filing Date 2026-08-13
Owner Merck Sharp & Dohme B.V. (Netherlands)
NICE Classes  ? 05 - Pharmaceutical, veterinary and sanitary products

Goods & Services

Pharmaceutical preparations for the treatment and prevention of bone, cardiovascular, central nervous system, dermatological, endocrine, hematological, hepatological, immunological, gastrointestinal, genitourinary, gynecological, metabolic, musculoskeletal, nephrological, neurological, oncological, ophthalmic, retinal, psychiatric, pulmonary, renal, respiratory, and urological diseases and disorders; Pharmaceutical preparations for the treatment and prevention of autoimmune diseases, asthma, cancer and tumors, chronic cough, diabetes, hypertension, insomnia, intestinal infections, skin disorders, and urinary incontinence; Inhalers filled with pharmaceutical preparations for the treatment of cardiovascular diseases and disorders; Antibacterial pharmaceuticals; Antibiotics; Antifungal preparations; Anti-infectives; Anti-inflammatories; Antiparasitics; Antivirals; Human vaccine preparations

17.

ZAKRASBY

      
Serial Number 50049242
Status Pending
Filing Date 2026-08-13
Owner Merck Sharp & Dohme B.V. (Netherlands)
NICE Classes  ? 05 - Pharmaceutical, veterinary and sanitary products

Goods & Services

Pharmaceutical preparations for the treatment and prevention of bone, cardiovascular, central nervous system, dermatological, endocrine, hematological, hepatological, immunological, gastrointestinal, genitourinary, gynecological, metabolic, musculoskeletal, nephrological, neurological, oncological, ophthalmic, retinal, psychiatric, pulmonary, renal, respiratory, and urological diseases and disorders; Pharmaceutical preparations for the treatment and prevention of autoimmune diseases, asthma, cancer and tumors, chronic cough, diabetes, hypertension, insomnia, intestinal infections, skin disorders, and urinary incontinence; Inhalers filled with pharmaceutical preparations for the treatment of cardiovascular diseases and disorders; Antibacterial pharmaceuticals; Antibiotics; Antifungal preparations; Anti-infectives; Anti-inflammatories; Antiparasitics; Antivirals; Human vaccine preparations

18.

ZAKRASLI

      
Serial Number 50049245
Status Pending
Filing Date 2026-08-13
Owner Merck Sharp & Dohme B.V. (Netherlands)
NICE Classes  ? 05 - Pharmaceutical, veterinary and sanitary products

Goods & Services

Pharmaceutical preparations for the treatment and prevention of bone, cardiovascular, central nervous system, dermatological, endocrine, hematological, hepatological, immunological, gastrointestinal, genitourinary, gynecological, metabolic, musculoskeletal, nephrological, neurological, oncological, ophthalmic, retinal, psychiatric, pulmonary, renal, respiratory, and urological diseases and disorders; Pharmaceutical preparations for the treatment and prevention of autoimmune diseases, asthma, cancer and tumors, chronic cough, diabetes, hypertension, insomnia, intestinal infections, skin disorders, and urinary incontinence; Inhalers filled with pharmaceutical preparations for the treatment of cardiovascular diseases and disorders; Antibacterial pharmaceuticals; Antibiotics; Antifungal preparations; Anti-infectives; Anti-inflammatories; Antiparasitics; Antivirals; Human vaccine preparations

19.

ZAKRASVO

      
Serial Number 50049247
Status Pending
Filing Date 2026-08-13
Owner Merck Sharp & Dohme B.V. (Netherlands)
NICE Classes  ? 05 - Pharmaceutical, veterinary and sanitary products

Goods & Services

Pharmaceutical preparations for the treatment and prevention of bone, cardiovascular, central nervous system, dermatological, endocrine, hematological, hepatological, immunological, gastrointestinal, genitourinary, gynecological, metabolic, musculoskeletal, nephrological, neurological, oncological, ophthalmic, retinal, psychiatric, pulmonary, renal, respiratory, and urological diseases and disorders; Pharmaceutical preparations for the treatment and prevention of autoimmune diseases, asthma, cancer and tumors, chronic cough, diabetes, hypertension, insomnia, intestinal infections, skin disorders, and urinary incontinence; Inhalers filled with pharmaceutical preparations for the treatment of cardiovascular diseases and disorders; Antibacterial pharmaceuticals; Antibiotics; Antifungal preparations; Anti-infectives; Anti-inflammatories; Antiparasitics; Antivirals; Human vaccine preparations

20.

CANINE ANTIBODIES TO CANINE IL-13

      
Application Number 19153746
Status Pending
Filing Date 2024-02-12
First Publication Date 2026-08-13
Owner INTERVET INC. (USA)
Inventor
  • Morsey, Mohamad
  • Qiao, Zhisong
  • Stauffer, Seth D.
  • Zhang, Yuanzheng

Abstract

The present invention provides canine antibodies that bind to canine interleukin-13 (canine IL-13) that have a high binding affinity for canine IL-13 and that can block the binding of canine IL-13 to the canine Type II heterodimer IL-4 receptor. The present invention also provides methods of using the antibodies of the present invention in the treatment of atopic dermatitis in dogs.

IPC Classes  ?

  • C07K 16/24 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies against material from animals or humans against cytokines, lymphokines or interferons
  • A61K 39/00 - Medicinal preparations containing antigens or antibodies
  • A61P 17/00 - Drugs for dermatological disorders
  • A61P 17/04 - Antipruritics
  • A61P 29/00 - Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agentsNon-steroidal antiinflammatory drugs [NSAID]

21.

CAYRASIG

      
Serial Number 50049200
Status Pending
Filing Date 2026-08-13
Owner Merck Sharp & Dohme B.V. (Netherlands)
NICE Classes  ? 05 - Pharmaceutical, veterinary and sanitary products

Goods & Services

Pharmaceutical preparations for the treatment and prevention of bone, cardiovascular, central nervous system, dermatological, endocrine, hematological, hepatological, immunological, gastrointestinal, genitourinary, gynecological, metabolic, musculoskeletal, nephrological, neurological, oncological, ophthalmic, retinal, psychiatric, pulmonary, renal, respiratory, and urological diseases and disorders; Pharmaceutical preparations for the treatment and prevention of autoimmune diseases, asthma, cancer and tumors, chronic cough, diabetes, hypertension, insomnia, intestinal infections, skin disorders, and urinary incontinence; Inhalers filled with pharmaceutical preparations for the treatment of cardiovascular diseases and disorders; Antibacterial pharmaceuticals; Antibiotics; Antifungal preparations; Anti-infectives; Anti-inflammatories; Antiparasitics; Antivirals; Human vaccine preparations

22.

KALSIMBRY

      
Serial Number 50049211
Status Pending
Filing Date 2026-08-13
Owner Merck Sharp & Dohme B.V. (Netherlands)
NICE Classes  ? 05 - Pharmaceutical, veterinary and sanitary products

Goods & Services

Pharmaceutical preparations for the treatment and prevention of bone, cardiovascular, central nervous system, dermatological, endocrine, hematological, hepatological, immunological, gastrointestinal, genitourinary, gynecological, metabolic, musculoskeletal, nephrological, neurological, oncological, ophthalmic, retinal, psychiatric, pulmonary, renal, respiratory, and urological diseases and disorders; Pharmaceutical preparations for the treatment and prevention of autoimmune diseases, asthma, cancer and tumors, chronic cough, diabetes, hypertension, insomnia, intestinal infections, skin disorders, and urinary incontinence; Inhalers filled with pharmaceutical preparations for the treatment of cardiovascular diseases and disorders; Antibacterial pharmaceuticals; Antibiotics; Antifungal preparations; Anti-infectives; Anti-inflammatories; Antiparasitics; Antivirals; Human vaccine preparations

23.

KAYRAZNI

      
Serial Number 50049217
Status Pending
Filing Date 2026-08-13
Owner Merck Sharp & Dohme B.V. (Netherlands)
NICE Classes  ? 05 - Pharmaceutical, veterinary and sanitary products

Goods & Services

Pharmaceutical preparations for the treatment and prevention of bone, cardiovascular, central nervous system, dermatological, endocrine, hematological, hepatological, immunological, gastrointestinal, genitourinary, gynecological, metabolic, musculoskeletal, nephrological, neurological, oncological, ophthalmic, retinal, psychiatric, pulmonary, renal, respiratory, and urological diseases and disorders; Pharmaceutical preparations for the treatment and prevention of autoimmune diseases, asthma, cancer and tumors, chronic cough, diabetes, hypertension, insomnia, intestinal infections, skin disorders, and urinary incontinence; Inhalers filled with pharmaceutical preparations for the treatment of cardiovascular diseases and disorders; Antibacterial pharmaceuticals; Antibiotics; Antifungal preparations; Anti-infectives; Anti-inflammatories; Antiparasitics; Antivirals; Human vaccine preparations

24.

KRIZLOKTA

      
Serial Number 50049221
Status Pending
Filing Date 2026-08-13
Owner Merck Sharp & Dohme B.V. (Netherlands)
NICE Classes  ? 05 - Pharmaceutical, veterinary and sanitary products

Goods & Services

Pharmaceutical preparations for the treatment and prevention of bone, cardiovascular, central nervous system, dermatological, endocrine, hematological, hepatological, immunological, gastrointestinal, genitourinary, gynecological, metabolic, musculoskeletal, nephrological, neurological, oncological, ophthalmic, retinal, psychiatric, pulmonary, renal, respiratory, and urological diseases and disorders; Pharmaceutical preparations for the treatment and prevention of autoimmune diseases, asthma, cancer and tumors, chronic cough, diabetes, hypertension, insomnia, intestinal infections, skin disorders, and urinary incontinence; Inhalers filled with pharmaceutical preparations for the treatment of cardiovascular diseases and disorders; Antibacterial pharmaceuticals; Antibiotics; Antifungal preparations; Anti-infectives; Anti-inflammatories; Antiparasitics; Antivirals; Human vaccine preparations

25.

ZAKBRILSA

      
Serial Number 50049223
Status Pending
Filing Date 2026-08-13
Owner Merck Sharp & Dohme B.V. (Netherlands)
NICE Classes  ? 05 - Pharmaceutical, veterinary and sanitary products

Goods & Services

Pharmaceutical preparations for the treatment and prevention of bone, cardiovascular, central nervous system, dermatological, endocrine, hematological, hepatological, immunological, gastrointestinal, genitourinary, gynecological, metabolic, musculoskeletal, nephrological, neurological, oncological, ophthalmic, retinal, psychiatric, pulmonary, renal, respiratory, and urological diseases and disorders; Pharmaceutical preparations for the treatment and prevention of autoimmune diseases, asthma, cancer and tumors, chronic cough, diabetes, hypertension, insomnia, intestinal infections, skin disorders, and urinary incontinence; Inhalers filled with pharmaceutical preparations for the treatment of cardiovascular diseases and disorders; Antibacterial pharmaceuticals; Antibiotics; Antifungal preparations; Anti-infectives; Anti-inflammatories; Antiparasitics; Antivirals; Human vaccine preparations

26.

KALKRASVI

      
Serial Number 50049227
Status Pending
Filing Date 2026-08-13
Owner Merck Sharp & Dohme B.V. (Netherlands)
NICE Classes  ? 05 - Pharmaceutical, veterinary and sanitary products

Goods & Services

Pharmaceutical preparations for the treatment and prevention of bone, cardiovascular, central nervous system, dermatological, endocrine, hematological, hepatological, immunological, gastrointestinal, genitourinary, gynecological, metabolic, musculoskeletal, nephrological, neurological, oncological, ophthalmic, retinal, psychiatric, pulmonary, renal, respiratory, and urological diseases and disorders; Pharmaceutical preparations for the treatment and prevention of autoimmune diseases, asthma, cancer and tumors, chronic cough, diabetes, hypertension, insomnia, intestinal infections, skin disorders, and urinary incontinence; Inhalers filled with pharmaceutical preparations for the treatment of cardiovascular diseases and disorders; Antibacterial pharmaceuticals; Antibiotics; Antifungal preparations; Anti-infectives; Anti-inflammatories; Antiparasitics; Antivirals; Human vaccine preparations

27.

KAZBILVY

      
Serial Number 50049231
Status Pending
Filing Date 2026-08-13
Owner Merck Sharp & Dohme B.V. (Netherlands)
NICE Classes  ? 05 - Pharmaceutical, veterinary and sanitary products

Goods & Services

Pharmaceutical preparations for the treatment and prevention of bone, cardiovascular, central nervous system, dermatological, endocrine, hematological, hepatological, immunological, gastrointestinal, genitourinary, gynecological, metabolic, musculoskeletal, nephrological, neurological, oncological, ophthalmic, retinal, psychiatric, pulmonary, renal, respiratory, and urological diseases and disorders; Pharmaceutical preparations for the treatment and prevention of autoimmune diseases, asthma, cancer and tumors, chronic cough, diabetes, hypertension, insomnia, intestinal infections, skin disorders, and urinary incontinence; Inhalers filled with pharmaceutical preparations for the treatment of cardiovascular diseases and disorders; Antibacterial pharmaceuticals; Antibiotics; Antifungal preparations; Anti-infectives; Anti-inflammatories; Antiparasitics; Antivirals; Human vaccine preparations

28.

SEFKRASY

      
Serial Number 50049238
Status Pending
Filing Date 2026-08-13
Owner Merck Sharp & Dohme B.V. (Netherlands)
NICE Classes  ? 05 - Pharmaceutical, veterinary and sanitary products

Goods & Services

Pharmaceutical preparations for the treatment and prevention of bone, cardiovascular, central nervous system, dermatological, endocrine, hematological, hepatological, immunological, gastrointestinal, genitourinary, gynecological, metabolic, musculoskeletal, nephrological, neurological, oncological, ophthalmic, retinal, psychiatric, pulmonary, renal, respiratory, and urological diseases and disorders; Pharmaceutical preparations for the treatment and prevention of autoimmune diseases, asthma, cancer and tumors, chronic cough, diabetes, hypertension, insomnia, intestinal infections, skin disorders, and urinary incontinence; Inhalers filled with pharmaceutical preparations for the treatment of cardiovascular diseases and disorders; Antibacterial pharmaceuticals; Antibiotics; Antifungal preparations; Anti-infectives; Anti-inflammatories; Antiparasitics; Antivirals; Human vaccine preparations

29.

WILOKRAS

      
Serial Number 50049240
Status Pending
Filing Date 2026-08-13
Owner Merck Sharp & Dohme B.V. (Netherlands)
NICE Classes  ? 05 - Pharmaceutical, veterinary and sanitary products

Goods & Services

Pharmaceutical preparations for the treatment and prevention of bone, cardiovascular, central nervous system, dermatological, endocrine, hematological, hepatological, immunological, gastrointestinal, genitourinary, gynecological, metabolic, musculoskeletal, nephrological, neurological, oncological, ophthalmic, retinal, psychiatric, pulmonary, renal, respiratory, and urological diseases and disorders; Pharmaceutical preparations for the treatment and prevention of autoimmune diseases, asthma, cancer and tumors, chronic cough, diabetes, hypertension, insomnia, intestinal infections, skin disorders, and urinary incontinence; Inhalers filled with pharmaceutical preparations for the treatment of cardiovascular diseases and disorders; Antibacterial pharmaceuticals; Antibiotics; Antifungal preparations; Anti-infectives; Anti-inflammatories; Antiparasitics; Antivirals; Human vaccine preparations

30.

Miscellaneous Design

      
Application Number 1931171
Status Registered
Filing Date 2026-04-23
Registration Date 2026-04-23
Owner Merck Sharp & Dohme B.V. (Netherlands)
NICE Classes  ? 05 - Pharmaceutical, veterinary and sanitary products

Goods & Services

Pharmaceutical preparations; human vaccine preparations.

31.

Process for Preparing Large Size Isoxazoline Particles

      
Application Number 19576639
Status Pending
Filing Date 2026-03-24
First Publication Date 2026-08-06
Owner Intervet Inc. (USA)
Inventor
  • Schenck, Luke Ryan
  • Koynov, Athanas
  • Zhou, George X.
  • Cote, Aaron

Abstract

An improved process to produce large isoxazoline compound particles which comprises initiating crystallization and then maintaining the temperature of the crystallization in the metastable region by removing, reheating and recycling a portion of the solvent thereby allowing the existing crystals to grow larger while minimizing the formation of newer smaller crystals.

IPC Classes  ?

  • C07D 261/04 - Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
  • A01N 43/80 - Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with nitrogen atoms and oxygen or sulfur atoms, as ring hetero atoms five-membered rings with one nitrogen atom and either one oxygen atom or one sulfur atom in positions 1,2

32.

A METHOD TO PRESERVE VIRUS LIKE PARTICLES OF FOOT AND MOUTH DISEASE VIRUS

      
Application Number EP2026052408
Publication Number 2026/162693
Status In Force
Filing Date 2026-01-30
Publication Date 2026-08-06
Owner
  • INTERVET INTERNATIONAL B.V. (Netherlands)
  • INTERVET INC. (USA)
Inventor
  • Kahl, Carina
  • Van Den Born, Erwin

Abstract

The invention pertains to a method to preserve recombinant virus-like particles (VLPs) of Foot and mouth disease virus (FMDV), which VLPs include one or more stabilizing mutations, the method comprising formulating the recombinant VLPs in an aqueous solution that comprises 1-50% (v/v) glycerol and thereafter cooling the solution to a temperature of at least -20˚C. The invention also pertains to an aqueous formulation comprising virus like particles of Foot and mouth disease virus, and to the use of this formulation as a vaccine to protect an animal against an infection with Foot and mouth disease virus.

IPC Classes  ?

  • A61K 39/12 - Viral antigens
  • A61P 31/14 - Antivirals for RNA viruses
  • C12N 7/00 - Viruses, e.g. bacteriophagesCompositions thereofPreparation or purification thereof
  • A61K 39/00 - Medicinal preparations containing antigens or antibodies

33.

PISCINE MYOCARDITIS VIRUS VACCINE

      
Application Number EP2026052430
Publication Number 2026/162707
Status In Force
Filing Date 2026-01-30
Publication Date 2026-08-06
Owner
  • INTERVET INTERNATIONAL B.V. (Netherlands)
  • INTERVET INC. (USA)
Inventor
  • Rouxel, Ronan
  • Langereis, Martijn, Alexander
  • Thim, Hanna L.
  • Villoing, Stephane

Abstract

The present invention relates to the field of veterinary vaccines, more specifically to a DNA vaccine for fish against piscine myocarditis virus (PMCV). In particular, the invention relates to a nucleic acid comprising a nucleotide sequence encoding a PMCV ORF3 protein or a variant or fragment thereof, with modifications in a specific region, as well as to a DNA expression vector comprising the nucleic acid sequence encoding the modified ORF 3, and to medical uses of said DNA expression vector as a vaccine for fish against PMCV.

IPC Classes  ?

  • A61K 39/12 - Viral antigens
  • A61P 31/14 - Antivirals for RNA viruses
  • C07K 14/005 - Peptides having more than 20 amino acidsGastrinsSomatostatinsMelanotropinsDerivatives thereof from viruses

34.

A SYSTEM AND METHOD FOR PROCESSING AMPOULES

      
Application Number 19149706
Status Pending
Filing Date 2024-01-26
First Publication Date 2026-08-06
Owner INTERVET INC. (USA)
Inventor
  • Swern, Michael Stephen
  • Casagrande, Henrique Augusto
  • Correa Barbosa, Taylor Marcelo
  • Collins, Michael Alexander

Abstract

A system for opening ampoules, the system comprising a beam comprising at least one opening for receiving part of an ampoule and an ampoule carrier for holding one or more ampoules. The system is configured to rotate the beam relative to the carrier, such that the rotation causes opposite sides of said opening to apply pressure to said received ampoule held by the carrier, to thereby break off said part of the ampoule received by the opening.

IPC Classes  ?

  • B67B 7/92 - Hand- or power-operated devices for opening closed containers by breaking, e.g. for ampoules
  • A61J 1/20 - Arrangements for transferring fluids, e.g. from vial to syringe

35.

SWINE INFLUENZA A VIRUS VACCINE COMPRISING A NUCLEIC ACID CONSTRUCT HAVING A SPECIFIC ORDER OF GENES

      
Application Number 19644538
Status Pending
Filing Date 2026-04-10
First Publication Date 2026-07-30
Owner Intervet Inc. (USA)
Inventor
  • Mogler, Mark A.
  • Nagaraj, Basav Hangalapura

Abstract

The present invention relates to a nucleic acid construct that encodes, in this order, a first Swine influenza A (IAV-S) hemagglutinin (HA) antigen of the Scot/94 lineage and a second Swine influenza A (IAV-S) hemagglutinin (HA) antigen of the Eurasian avian-like (EA) lineage, and a nucleic acid construct that encodes, in this order, a first IAV-S HA antigen of the Gent/84 lineage and a second IAV-S HA antigen of pandemic09 (pdm09) lineage. In other embodiments, the present invention relates to RNA replicon particles comprising one or both nucleic acid constructs, an immunogenic composition, such as a vaccine, which may be used against influenza A virus infections, and comprising the replicon particles. Further provided are methods of making the vaccine and use of the vaccine.

IPC Classes  ?

  • C07K 14/11 - Orthomyxoviridae, e.g. influenza virus
  • A61K 39/00 - Medicinal preparations containing antigens or antibodies
  • A61P 31/16 - Antivirals for RNA viruses for influenza or rhinoviruses
  • C12N 15/86 - Viral vectors

36.

PROCESSES FOR MAKING ENDOCHIN-LIKE QUINOLONES FROM ALKYL 3-(3-ALKOXYPHENYL)AMINO)-2-(4-(4-ALKOXY)PHENOXY)PHENYL)BUT-2-ENOATE

      
Application Number 19134492
Status Pending
Filing Date 2023-12-06
First Publication Date 2026-07-23
Owner INTERVET INC. (USA)
Inventor
  • Chassaing, Christophe Pierre Alain
  • Veit, Stephan

Abstract

A new scalable synthesis for the preparation of endochin-like quinolone compounds of Formula (I), wherein R is H, Cl or F, and R2 is C1-C2 alkyl, wherein the synthesis comprises is a process for preparing a compound of Formula (5) wherein R1 is C1-C2 alkyl, preferably C1 alkyl. A new scalable synthesis for the preparation of endochin-like quinolone compounds of Formula (I), wherein R is H, Cl or F, and R2 is C1-C2 alkyl, wherein the synthesis comprises is a process for preparing a compound of Formula (5) wherein R1 is C1-C2 alkyl, preferably C1 alkyl.

IPC Classes  ?

  • C07C 67/31 - Preparation of carboxylic acid esters by modifying the acid moiety of the ester, such modification not being an introduction of an ester group by introduction of functional groups containing oxygen only in singly bound form
  • C07C 69/734 - Ethers
  • C07D 215/22 - Oxygen atoms attached in position 2 or 4

37.

Miscellaneous Design

      
Serial Number 99943816
Status Pending
Filing Date 2026-07-16
Owner Intervet Inc. (USA)
NICE Classes  ? 05 - Pharmaceutical, veterinary and sanitary products

Goods & Services

Veterinary preparations for the treatment of cancer

38.

Miscellaneous Design

      
Serial Number 99943821
Status Pending
Filing Date 2026-07-16
Owner Intervet Inc. (USA)
NICE Classes  ? 05 - Pharmaceutical, veterinary and sanitary products

Goods & Services

Veterinary preparations for the treatment of cancer

39.

OZEQVO

      
Application Number 019395567
Status Pending
Filing Date 2026-07-15
Owner Merck Sharp & Dohme B.V. (Netherlands)
NICE Classes  ? 05 - Pharmaceutical, veterinary and sanitary products

Goods & Services

Pharmaceutical preparations for use in oncology.

40.

EYWINTIZ

      
Application Number 1926592
Status Registered
Filing Date 2026-06-04
Registration Date 2026-06-04
Owner Merck Sharp & Dohme B.V. (Netherlands)
NICE Classes  ? 05 - Pharmaceutical, veterinary and sanitary products

Goods & Services

Pharmaceutical preparations; human vaccine preparations.

41.

VACCINE FOR PROTECTION AGAINST LEPTOSPIRA SEROVAR AUSTRALIS

      
Application Number 18873757
Status Pending
Filing Date 2023-06-21
First Publication Date 2026-07-09
Owner INTERVET INC. (USA)
Inventor
  • Klaasen, Henricus Leo Bernardus Maria
  • Hegge, Jorrit

Abstract

The present invention is directed to providing a canine with protective immunity against Leptospira serovar Australis with a vaccine that comprises a non-Australis leptospira serovar.

IPC Classes  ?

42.

TILVIGHT

      
Serial Number 99918428
Status Pending
Filing Date 2026-07-02
Owner Merck Sharp & Dohme B.V. (Netherlands)
NICE Classes  ? 05 - Pharmaceutical, veterinary and sanitary products

Goods & Services

Pharmaceutical preparations for the treatment and prevention of bone, cardiovascular, central nervous system, dermatological, endocrine, hematological, hepatological, immunological, gastrointestinal, genitourinary, gynecological, metabolic, musculoskeletal, nephrological, neurological, oncological, ophthalmic, psychiatric, pulmonary, renal, respiratory, and urological diseases and disorders; Pharmaceutical preparations for the treatment and prevention of autoimmune diseases, asthma, cancer and tumors, chronic cough, diabetes, hypertension, insomnia, intestinal infections, skin disorders, and urinary incontinence; Inhalers filled with pharmaceutical preparations for the treatment of cardiovascular diseases and disorders; Antibacterial pharmaceuticals; Antibiotics; Antifungal preparations; Anti-infectives; Anti-inflammatories; Antiparasitics; Antivirals; Human vaccine preparations

43.

WYNTORFI

      
Application Number 1926376
Status Registered
Filing Date 2026-06-04
Registration Date 2026-06-04
Owner Merck Sharp & Dohme B.V. (Netherlands)
NICE Classes  ? 05 - Pharmaceutical, veterinary and sanitary products

Goods & Services

Pharmaceutical preparations; human vaccine preparations.

44.

OCWINTLA

      
Application Number 1926377
Status Registered
Filing Date 2026-06-04
Registration Date 2026-06-04
Owner Merck Sharp & Dohme B.V. (Netherlands)
NICE Classes  ? 05 - Pharmaceutical, veterinary and sanitary products

Goods & Services

Pharmaceutical preparations; human vaccine preparations.

45.

WYNTAVANZ

      
Application Number 1926380
Status Registered
Filing Date 2026-06-04
Registration Date 2026-06-04
Owner Merck Sharp & Dohme B.V. (Netherlands)
NICE Classes  ? 05 - Pharmaceutical, veterinary and sanitary products

Goods & Services

Pharmaceutical preparations; human vaccine preparations.

46.

OMDOVA

      
Application Number 1926381
Status Registered
Filing Date 2026-06-04
Registration Date 2026-06-04
Owner Merck Sharp & Dohme B.V. (Netherlands)
NICE Classes  ? 05 - Pharmaceutical, veterinary and sanitary products

Goods & Services

Pharmaceutical preparations; human vaccine preparations.

47.

RITVYVI

      
Application Number 1926384
Status Registered
Filing Date 2026-06-04
Registration Date 2026-06-04
Owner Merck Sharp & Dohme B.V. (Netherlands)
NICE Classes  ? 05 - Pharmaceutical, veterinary and sanitary products

Goods & Services

Pharmaceutical preparations; human vaccine preparations.

48.

ENRETFY

      
Application Number 1926385
Status Registered
Filing Date 2026-06-04
Registration Date 2026-06-04
Owner Merck Sharp & Dohme B.V. (Netherlands)
NICE Classes  ? 05 - Pharmaceutical, veterinary and sanitary products

Goods & Services

Pharmaceutical preparations; human vaccine preparations.

49.

EYWINTAZ

      
Application Number 1926386
Status Registered
Filing Date 2026-06-04
Registration Date 2026-06-04
Owner Merck Sharp & Dohme B.V. (Netherlands)
NICE Classes  ? 05 - Pharmaceutical, veterinary and sanitary products

Goods & Services

Pharmaceutical preparations; human vaccine preparations.

50.

TULWAIV

      
Serial Number 99918427
Status Pending
Filing Date 2026-07-02
Owner Merck Sharp & Dohme B.V. (Netherlands)
NICE Classes  ? 05 - Pharmaceutical, veterinary and sanitary products

Goods & Services

Pharmaceutical preparations for the treatment and prevention of bone, cardiovascular, central nervous system, dermatological, endocrine, hematological, hepatological, immunological, gastrointestinal, genitourinary, gynecological, metabolic, musculoskeletal, nephrological, neurological, oncological, ophthalmic, psychiatric, pulmonary, renal, respiratory, and urological diseases and disorders; Pharmaceutical preparations for the treatment and prevention of autoimmune diseases, asthma, cancer and tumors, chronic cough, diabetes, hypertension, insomnia, intestinal infections, skin disorders, and urinary incontinence; Inhalers filled with pharmaceutical preparations for the treatment of cardiovascular diseases and disorders; Antibacterial pharmaceuticals; Antibiotics; Antifungal preparations; Anti-infectives; Anti-inflammatories; Antiparasitics; Antivirals; Human vaccine preparations

51.

WYNIKTO

      
Application Number 1926378
Status Registered
Filing Date 2026-06-04
Registration Date 2026-06-04
Owner Merck Sharp & Dohme B.V. (Netherlands)
NICE Classes  ? 05 - Pharmaceutical, veterinary and sanitary products

Goods & Services

Pharmaceutical preparations; human vaccine preparations.

52.

VIZWYNLA

      
Application Number 1926379
Status Registered
Filing Date 2026-06-04
Registration Date 2026-06-04
Owner Merck Sharp & Dohme B.V. (Netherlands)
NICE Classes  ? 05 - Pharmaceutical, veterinary and sanitary products

Goods & Services

Pharmaceutical preparations; human vaccine preparations.

53.

APVIMRET

      
Application Number 1926382
Status Registered
Filing Date 2026-06-04
Registration Date 2026-06-04
Owner Merck Sharp & Dohme B.V. (Netherlands)
NICE Classes  ? 05 - Pharmaceutical, veterinary and sanitary products

Goods & Services

Pharmaceutical preparations; human vaccine preparations.

54.

ADANVYZ

      
Application Number 1926387
Status Registered
Filing Date 2026-06-04
Registration Date 2026-06-04
Owner Merck Sharp & Dohme B.V. (Netherlands)
NICE Classes  ? 05 - Pharmaceutical, veterinary and sanitary products

Goods & Services

Pharmaceutical preparations; human vaccine preparations.

55.

A NOVEL SYNTHESIS OF ETHYL 3-AMINO-1((3R,4S)-4-CYANOTETRAHYDRO-2H-PYRAN-3-YL)-1H-PYRAZOLE-4-CARBOXYLATE

      
Application Number EP2025087661
Publication Number 2026/132007
Status In Force
Filing Date 2025-12-17
Publication Date 2026-06-25
Owner
  • INTERVET INTERNATIONAL B.V. (Netherlands)
  • INTERVET INC. (USA)
Inventor
  • Sekher, Padmanabhan
  • Dupati, Gautam
  • Aavula, Sanjeev Kumar
  • Dibenedetto, Michael

Abstract

A novel synthesis of ethyl 3-amino-l-((3R,4S)-4-cyanotetrahydro-2H- pyran-3-yl)-lH-pyrazole-4-carboxylate, an intermediate used in the manufacturing of atinvicitinib, without the use of chiral chromatographic separation.

IPC Classes  ?

  • C07D 309/26 - Carboxaldehyde radicals
  • C07D 405/04 - Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring- member bond

56.

MIUDELLA

      
Serial Number 99906245
Status Pending
Filing Date 2026-06-25
Owner N.V. ORGANON (Netherlands)
NICE Classes  ?
  • 05 - Pharmaceutical, veterinary and sanitary products
  • 10 - Medical apparatus and instruments

Goods & Services

Medicines and pharmaceutical preparations for human use, namely, contraceptives; contraceptive pharmaceutical preparations contained in and released from an intrauterine device Intra-uterine contraceptive devices containing copper

57.

SERUM FREE INTRACELLULAR PATHOGEN VACCINE

      
Document Number 03313378
Status Pending
Filing Date 2019-12-20
Open to Public Date 2026-06-21
Owner INTERVET INTERNATIONAL B.V. (Netherlands)
Inventor
  • Koumans, Joseph
  • Frost, Petter
  • Forlenza, Maria

Abstract

A vaccine composition comprising a virus antigen wherein the composition comprises less than 5% serum, wherein the virus antigen is a whole virus or derived from a whole virus. the vaccine composition reduces, prevents or avoids cross-stitch spinal deformity in the treated animal.

IPC Classes  ?

58.

GENDERLESS INTERFACE CONNECTOR PULL TOOL

      
Application Number 19533672
Status Pending
Filing Date 2026-02-09
First Publication Date 2026-06-18
Owner MSD International GmbH (Switzerland)
Inventor
  • Lahart, Noel
  • Mullarkey, Brian
  • Hayes, John

Abstract

A genderless interface connector pull tool is used for removing a membrane from a genderless interface connector. The tool may include a clamp and a hand grip. The clamp is configured to clamp a genderless interface connector and may include a top clamp coupled with a bottom clamp, and one or more rails located on a top surface of the top clamp. The hand grip may include a grip head which is formed with a hook and one or more openings. The hook is configured to engage with a tab of the genderless interface connector that is connected to a membrane. The one or more openings are dimensioned to fit with the one or more rails so that the hand grip can slide on the rails to pull the tab. Thus, the membrane connected to the tab can be removed from the genderless interface connector along the rails'direction.

IPC Classes  ?

  • B25B 27/02 - Hand tools or bench devices, specially adapted for fitting together or separating parts or objects whether or not involving some deformation, not otherwise provided for for connecting objects by press fit or detaching same
  • F16L 33/02 - Hose-clips

59.

AN ORAL LIQUID PHARMACEUTICAL COMPOSITION OF ERTUGLIFLOZIN

      
Application Number EP2025086008
Publication Number 2026/125319
Status In Force
Filing Date 2025-12-09
Publication Date 2026-06-18
Owner
  • INTERVET INTERNATIONAL B.V. (Netherlands)
  • INTERVET INC. (USA)
Inventor
  • Kowalski, Timothy J.
  • Kulczar, Christopher D.
  • Su, Kevin Huiheng
  • Wang, Chen-Chao

Abstract

An oral liquid liquid pharmaceutical composition comprising a) a pharmaceutically effective amount of a compound of Formula (I) or a salt thereof, b) a poloxamer, and c) a solvent.

IPC Classes  ?

  • A61K 9/00 - Medicinal preparations characterised by special physical form
  • A61K 9/08 - Solutions
  • A61K 31/7048 - Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin
  • A61K 47/10 - AlcoholsPhenolsSalts thereof, e.g. glycerolPolyethylene glycols [PEG]PoloxamersPEG/POE alkyl ethers
  • A61K 47/14 - Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
  • A61K 47/26 - Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharidesDerivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin

60.

CANINIZED IL31RΑ ANTIBODIES WITH AN EXTENDED HALF LIFE

      
Application Number EP2025086009
Publication Number 2026/125320
Status In Force
Filing Date 2025-12-09
Publication Date 2026-06-18
Owner
  • INTERVET INTERNATIONAL B.V. (Netherlands)
  • INTERVET INC. (USA)
Inventor
  • Morsey, Mohamad
  • Qiao, Zhisong
  • Restis, Eva
  • Ryan-Simkins, Michael A.

Abstract

The present invention generally relates to canine IgG antibodies or antigen binding proteins thereof, comprising a canine IgG modified fragment crystallizable region (Fc region) that has an enhanced half-life due to one or more specific amino acid substitutions in the Fc region. Specifically, the present invention relates to canine antibodies and antigen binding fragments thereof, that bind canine interleukin-31 receptor alpha (IL31RA), comprising a canine fragment crystallizable region (cFc) that comprises two, three, four or more specific amino acids at defined positions, such as 428, 434, 436, 438 and 440 in the cFc region. Pharmaceutical compositions that comprise these antibodies are also provided.

IPC Classes  ?

  • A61P 17/00 - Drugs for dermatological disorders
  • C07K 16/28 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants

61.

AN ORAL LIQUID PHARMACEUTICAL COMPOSITION OF ERTUGLIFLOZIN

      
Application Number EP2025086112
Publication Number 2026/125363
Status In Force
Filing Date 2025-12-09
Publication Date 2026-06-18
Owner
  • INTERVET INTERNATIONAL B.V. (Netherlands)
  • INTERVET INC. (USA)
Inventor
  • Kulczar, Christopher, D
  • Su, Kevin Huiheng
  • Kowalski, Timothy J.

Abstract

An oral liquid pharmaceutical composition comprising a) a pharmaceutically effective amount of a compound of Formula (I) or a salt thereof, b) a polyethylene glycol (PEG), and c) a solvent wherein in the pH of the oral liquid pharmaceutical composition is between about 3.0 to about

IPC Classes  ?

  • A61K 9/00 - Medicinal preparations characterised by special physical form
  • A61K 9/08 - Solutions
  • A61K 31/7048 - Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin
  • A61K 47/10 - AlcoholsPhenolsSalts thereof, e.g. glycerolPolyethylene glycols [PEG]PoloxamersPEG/POE alkyl ethers
  • A61K 47/14 - Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
  • A61K 47/22 - Heterocyclic compounds, e.g. ascorbic acid, tocopherol or pyrrolidones
  • A61K 47/26 - Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharidesDerivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin

62.

CANINIZED IL31RΑ ANTIBODIES WITH AN EXTENDED HALF LIFE

      
Application Number EP2025086010
Publication Number 2026/125321
Status In Force
Filing Date 2025-12-09
Publication Date 2026-06-18
Owner
  • INTERVET INTERNATIONAL B.V. (Netherlands)
  • INTERVET INC. (USA)
Inventor
  • Morsey, Mohamad
  • Qiao, Zhisong
  • Restis, Eva
  • Ryan-Simkins, Michael A.

Abstract

The present invention generally relates to canine IgG antibodies or antigen binding proteins thereof, comprising a canine IgG modified fragment crystallizable region (Fc region) that has an enhanced half-life due to one or more specific amino acid substitutions in the Fc region. Specifically, the present invention relates to canine antibodies that bind canine interleukin-31 receptor alpha (IL31RA), comprising a canine fragment crystallizable region (cFc) that comprises an amino acid residue other than glutamine (Q) at position 311. Pharmaceutical compositions that comprise these antibodies are also provided.

IPC Classes  ?

  • C07K 16/28 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
  • A61P 37/00 - Drugs for immunological or allergic disorders

63.

CANINIZED IL31Rα ANTIBODIES WITH AN EXTENDED HALF LIFE

      
Application Number EP2025086011
Publication Number 2026/125322
Status In Force
Filing Date 2025-12-09
Publication Date 2026-06-18
Owner
  • INTERVET INTERNATIONAL B.V. (Netherlands)
  • INTERVET INC. (USA)
Inventor
  • Morsey, Mohamad
  • Qiao, Zhisong
  • Restis, Eva
  • Ryan-Simkins, Michael A.

Abstract

The present invention generally relates to canine IgG antibodies or antigen binding proteins thereof, comprising a canine IgG modified fragment crystallizable region (Fc region) that has an enhanced half-life due to one or more specific amino acid substitutions in the Fc region. Specifically, the present invention relates to canine antibodies that bind canine interleukin-31 receptor alpha (IL31RA), comprising a canine fragment crystallizable region (cFc) that comprises an amino acid residue other than Leucine at position 252. Pharmaceutical compositions that comprise these antibodies are also provided.

IPC Classes  ?

  • C07K 16/28 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
  • A61P 37/00 - Drugs for immunological or allergic disorders

64.

CRYSTALLINE FORMS OF ERTUGLIFLOZIN

      
Application Number EP2025086111
Publication Number 2026/125362
Status In Force
Filing Date 2025-12-09
Publication Date 2026-06-18
Owner
  • INTERVET INTERNATIONAL B.V. (Netherlands)
  • INTERVET INC. (USA)
Inventor
  • Lee, Alfred
  • Fattel, Hoda

Abstract

New forms of ertugliflozin were discovered that are more stable than ertugliflozin LPGA cocrystal in aqueous media.

IPC Classes  ?

  • C07D 493/08 - Bridged systems
  • A61P 3/10 - Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
  • C07H 1/06 - SeparationPurification
  • A61K 31/7048 - Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin

65.

SERUM FREE INTRACELLULAR PATHOGEN VACCINE

      
Application Number 19465533
Status Pending
Filing Date 2026-01-30
First Publication Date 2026-06-11
Owner Intervet Inc. (USA)
Inventor
  • Koumans, Joseph
  • Frost, Petter
  • Forlenza, Maria

Abstract

A vaccine composition comprising a virus antigen wherein the composition comprises less than 5% serum, wherein the virus antigen is a whole virus or derived from a whole virus. the vaccine composition reduces, prevents or avoids cross-stitch spinal deformity in the treated animal

IPC Classes  ?

  • A61K 39/205 - Rhabdoviridae, e.g. rabies virus
  • A23K 10/16 - Addition of microorganisms or extracts thereof, e.g. single-cell proteins, to feeding-stuff compositions
  • A23K 10/18 - Addition of microorganisms or extracts thereof, e.g. single-cell proteins, to feeding-stuff compositions of live microorganisms
  • A23K 10/24 - Animal feeding-stuffs from material of animal origin from blood
  • A23K 20/147 - Polymeric derivatives, e.g. peptides or proteins
  • A23K 50/80 - Feeding-stuffs specially adapted for particular animals for aquatic animals, e.g. fish, crustaceans or molluscs
  • A61K 35/16 - Blood plasmaBlood serum
  • A61K 39/00 - Medicinal preparations containing antigens or antibodies
  • A61K 39/002 - Protozoa antigens
  • A61K 39/005 - Trypanosoma antigens
  • A61K 39/02 - Bacterial antigens
  • A61K 39/12 - Viral antigens
  • A61K 39/145 - Orthomyxoviridae, e.g. influenza virus
  • A61P 31/12 - Antivirals

66.

OCWINTLA

      
Application Number 248588000
Status Pending
Filing Date 2026-06-04
Owner Merck Sharp & Dohme B.V. (Netherlands)
NICE Classes  ? 05 - Pharmaceutical, veterinary and sanitary products

Goods & Services

(1) Pharmaceutical preparations; human vaccine preparations.

67.

APVIMRET

      
Application Number 248588800
Status Pending
Filing Date 2026-06-04
Owner Merck Sharp & Dohme B.V. (Netherlands)
NICE Classes  ? 05 - Pharmaceutical, veterinary and sanitary products

Goods & Services

(1) Pharmaceutical preparations; human vaccine preparations.

68.

WYNIKTO

      
Application Number 248588100
Status Pending
Filing Date 2026-06-04
Owner Merck Sharp & Dohme B.V. (Netherlands)
NICE Classes  ? 05 - Pharmaceutical, veterinary and sanitary products

Goods & Services

(1) Pharmaceutical preparations; human vaccine preparations.

69.

OMDOVA

      
Application Number 248588500
Status Pending
Filing Date 2026-06-04
Owner Merck Sharp & Dohme B.V. (Netherlands)
NICE Classes  ? 05 - Pharmaceutical, veterinary and sanitary products

Goods & Services

(1) Pharmaceutical preparations; human vaccine preparations.

70.

STABLE VACCINE AGAINST STREPTOCOCCUS SUIS

      
Application Number EP2025084326
Publication Number 2026/114933
Status In Force
Filing Date 2025-11-26
Publication Date 2026-06-04
Owner
  • INTERVET INTERNATIONAL B.V. (Netherlands)
  • INTERVET INC. (USA)
Inventor
  • Jacobs, Antonius, Arnoldus, Christiaan
  • Van Kasteren - Westerneng, Theodora, Johanna
  • Grommen, Andreas Wilhelmus Francisca

Abstract

S. suisS. suis bacteria. The invention also pertains to methods of preparing the vaccine formulation, preferably wherein the method comprises a step of lyophilizing the vaccine formulation.

IPC Classes  ?

71.

CARBOXAMIDE-4-QUINOLINE COMPOUNDS WITH ANTHELMINTIC ACTIVITY

      
Application Number EP2025084521
Publication Number 2026/115027
Status In Force
Filing Date 2025-11-27
Publication Date 2026-06-04
Owner
  • INTERVET INTERNATIONAL B.V. (Netherlands)
  • INTERVET INC. (USA)
Inventor
  • Berger, Michael
  • Tänzler, Janina

Abstract

Ascaridia, Oesophagostomum, HaemonchusDirofilariaDirofilaria.

IPC Classes  ?

  • C07D 215/50 - Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen attached in position 4
  • A61P 33/10 - Anthelmintics
  • A61K 31/47 - QuinolinesIsoquinolines

72.

RITVYVI

      
Application Number 248588400
Status Pending
Filing Date 2026-06-04
Owner Merck Sharp & Dohme B.V. (Netherlands)
NICE Classes  ? 05 - Pharmaceutical, veterinary and sanitary products

Goods & Services

(1) Pharmaceutical preparations; human vaccine preparations.

73.

VIZWYNLA

      
Application Number 248588200
Status Pending
Filing Date 2026-06-04
Owner Merck Sharp & Dohme B.V. (Netherlands)
NICE Classes  ? 05 - Pharmaceutical, veterinary and sanitary products

Goods & Services

(1) Pharmaceutical preparations; human vaccine preparations.

74.

EYWINTIZ

      
Application Number 248739200
Status Pending
Filing Date 2026-06-04
Owner Merck Sharp & Dohme B.V. (Netherlands)
NICE Classes  ? 05 - Pharmaceutical, veterinary and sanitary products

Goods & Services

(1) Pharmaceutical preparations; human vaccine preparations.

75.

ADANVYZ

      
Application Number 248589000
Status Pending
Filing Date 2026-06-04
Owner Merck Sharp & Dohme B.V. (Netherlands)
NICE Classes  ? 05 - Pharmaceutical, veterinary and sanitary products

Goods & Services

(1) Pharmaceutical preparations; human vaccine preparations.

76.

WYNTORFI

      
Application Number 248587900
Status Pending
Filing Date 2026-06-04
Owner Merck Sharp & Dohme B.V. (Netherlands)
NICE Classes  ? 05 - Pharmaceutical, veterinary and sanitary products

Goods & Services

(1) Pharmaceutical preparations; human vaccine preparations.

77.

ENRETFY

      
Application Number 248588900
Status Pending
Filing Date 2026-06-04
Owner Merck Sharp & Dohme B.V. (Netherlands)
NICE Classes  ? 05 - Pharmaceutical, veterinary and sanitary products

Goods & Services

(1) Pharmaceutical preparations; human vaccine preparations.

78.

EYWINTAZ

      
Application Number 248588700
Status Pending
Filing Date 2026-06-04
Owner Merck Sharp & Dohme B.V. (Netherlands)
NICE Classes  ? 05 - Pharmaceutical, veterinary and sanitary products

Goods & Services

(1) Pharmaceutical preparations; human vaccine preparations.

79.

WYNTAVANZ

      
Application Number 248588300
Status Pending
Filing Date 2026-06-04
Owner Merck Sharp & Dohme B.V. (Netherlands)
NICE Classes  ? 05 - Pharmaceutical, veterinary and sanitary products

Goods & Services

(1) Pharmaceutical preparations; human vaccine preparations.

80.

ISOXAZOLINE ORAL COMPOSITIONS FOR ECTOPARASITE CONTROL IN LIVESTOCK ANIMALS

      
Application Number EP2025084509
Publication Number 2026/115021
Status In Force
Filing Date 2025-11-27
Publication Date 2026-06-04
Owner
  • INTERVET INTERNATIONAL B.V. (Netherlands)
  • INTERVET INC. (USA)
Inventor
  • Assis, Ulisses, Rafael, Santos
  • Soares Moran, Mariana
  • Vettorato, Luis, Fernando,
  • Bonomi Barufi, Francisco
  • De Oliveira Arriero Amaral, Heitor
  • Cortez, Luiz, Daniel
  • Barreto, Willian Douglas

Abstract

The present invention relates to an oral liquid veterinary pharmaceutical composition comprising an isoxazoline compound selected from the group consisting of fluralaner, afoxolaner, lotilaner, and sarolaner, designed to effectively treat and control ectoparasite infestations in livestock, specifically cattle. The composition is formulated as a ready-to-use aqueous suspension that includes a viscosity agent, surfactant, and suspending agent.

IPC Classes  ?

  • A61K 9/00 - Medicinal preparations characterised by special physical form
  • A61K 31/42 - Oxazoles
  • A61K 31/422 - Oxazoles not condensed and containing further heterocyclic rings
  • A61P 33/14 - Ectoparasiticides, e.g. scabicides
  • A61K 9/10 - DispersionsEmulsions
  • A61K 47/10 - AlcoholsPhenolsSalts thereof, e.g. glycerolPolyethylene glycols [PEG]PoloxamersPEG/POE alkyl ethers
  • A61K 47/20 - Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing sulfur, e.g. dimethyl sulfoxide [DMSO], docusate, sodium lauryl sulfate or aminosulfonic acids

81.

JOYAMITY

      
Application Number 1919239
Status Registered
Filing Date 2026-03-10
Registration Date 2026-03-10
Owner Merck Sharp & Dohme B.V. (Netherlands)
NICE Classes  ? 05 - Pharmaceutical, veterinary and sanitary products

Goods & Services

Pharmaceutical preparations; human vaccine preparations.

82.

JOYNEXTY

      
Application Number 1919236
Status Registered
Filing Date 2026-03-10
Registration Date 2026-03-10
Owner Merck Sharp & Dohme B.V. (Netherlands)
NICE Classes  ? 05 - Pharmaceutical, veterinary and sanitary products

Goods & Services

Pharmaceutical preparations; human vaccine preparations.

83.

IDVYNSO

      
Application Number 019368670
Status Pending
Filing Date 2026-05-21
Owner Merck Sharp & Dohme B.V. (Netherlands)
NICE Classes  ? 05 - Pharmaceutical, veterinary and sanitary products

Goods & Services

Pharmaceutical preparations, namely, anti-infectives and antivirals.

84.

SYSTEM AND METHOD FOR ESTIMATING GREENHOUSE GAS EMISSIONS IN AN ENVIRONMENT HOUSING AN ANIMAL POPULATION

      
Application Number 19447003
Status Pending
Filing Date 2026-01-13
First Publication Date 2026-05-21
Owner
  • S.C.R. (ENGINEERS) LIMITED (Israel)
  • MERCK SHARP & DOHME ANIMAL HEALTH, S.L. (Spain)
Inventor
  • Genzel, Eran
  • Rabinovitz, Rotem
  • Bar, Doron
  • Campillo Benéitez, Juan Pedro

Abstract

A system for estimating greenhouse gas emission in an environment housing an animal population, the system comprising: one or more monitoring devices configured to monitor parameters of members of the animal population; a data repository comprising one or more records, each of the records (i) being associated with a respective member of the members, and (ii) including one or more parameters of the respective member as monitored by at least one of the monitoring devices over time; and a processing circuitry configured to: obtain at least a subset of the records, the subset being associated with a group of members of the animal population; determine one or more greenhouse gas emission affecting parameters based on the subset; estimate an amount of greenhouse gas emission in the environment utilizing the greenhouse gas emission affecting parameters; and perform an action utilizing the estimated amount of greenhouse gas emission in the environment.

IPC Classes  ?

  • G06Q 30/018 - Certifying business or products
  • G06Q 10/0639 - Performance analysis of employeesPerformance analysis of enterprise or organisation operations
  • G06Q 50/02 - AgricultureFishingForestryMining

85.

CRYSTALLINE FORMS OF 1-[(3R,4S)-4-CYANOTETRAHYDROPYRAN-3-YL]-3-[(2-FLUORO-6-METHOXY-4-PYRIDYL)AMINO]PYRAZOLE-4-CARBOXAMIDE

      
Document Number 03303259
Status Pending
Filing Date 2019-12-12
Open to Public Date 2026-05-13
Owner INTERVET INTERNATIONAL B.V. (Netherlands)
Inventor
  • Chassaing, Christophe Pierre Alain
  • Jin, Xiaoling
  • Petrova, Rositza Iordanova
  • Varsolona, Richard J.
  • Codan, Lorenzo
  • Cleator, Edward
  • Goodyear, Adrian
  • Simmons, Jonathan
  • Schweisel, Tanja

Abstract

The present application relates to crystalline forms of 1[(3R,4S)41-[(3R,4S)-4- cyanotetrahydropyran-3-yl]-3-[(2-fluoro-6-methoxy-4-pyridyl) amino]pyrazole-4- carboxamide and processes for the preparation thereof. The compound is useful for the treatment of JAK-mediated diseases or conditions such as atopic dermatitis.

IPC Classes  ?

  • A61K 31/4439 - Non-condensed pyridinesHydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
  • A61P 17/00 - Drugs for dermatological disorders
  • A61P 17/04 - Antipruritics
  • A61P 19/02 - Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
  • A61P 35/00 - Antineoplastic agents
  • C07D 405/14 - Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings

86.

MERCK CASH-PAY GATEWAY

      
Serial Number 99818318
Status Pending
Filing Date 2026-05-12
Owner Merck Sharp & Dohme B.V. (Netherlands)
NICE Classes  ?
  • 09 - Scientific and electric apparatus and instruments
  • 35 - Advertising and business services
  • 42 - Scientific, technological and industrial services, research and design
  • 44 - Medical, veterinary, hygienic and cosmetic services; agriculture, horticulture and forestry services

Goods & Services

Downloadable computer software for enabling patients to request, receive, track shipment of, and manage prescriptions and orders for pharmaceuticals.; Downloadable computer software for receiving, managing, filling, and providing information about prescription pharmaceutical orders Mail order pharmacy services; Pharmacy services; Online retail pharmacy services Online computer software for enabling patients to request, receive, track shipment of, and manage prescriptions and orders for pharmaceuticals.; Online computer software for receiving, managing, filling, and providing information about prescription pharmaceutical orders Healthcare services; Telemedicine services; Providing medical information in the field of healthcare, pharmaceuticals, medicines, health conditions, diseases, disorders, and treatment options.

87.

YOUR HIVE OF WHOLE HEALTH

      
Serial Number 99811829
Status Pending
Filing Date 2026-05-08
Owner Merck Sharp & Dohme B.V. (Netherlands)
NICE Classes  ?
  • 09 - Scientific and electric apparatus and instruments
  • 16 - Paper, cardboard and goods made from these materials
  • 42 - Scientific, technological and industrial services, research and design
  • 44 - Medical, veterinary, hygienic and cosmetic services; agriculture, horticulture and forestry services

Goods & Services

Downloadable educational course materials in the field of HIV; Downloadable written articles in the field of HIV Printed educational course materials in the field of HIV; Printed articles in the field of HIV Providing a website featuring technology that enables users to receive emotional support, information, education and practical assistance for patients with HIV, their loved ones, caregivers and professionals Providing a website featuring information in the field of HIV health; Providing a website featuring information in the field of the diagnosis and treatment of HIV

88.

CANINIZED ANTIBODIES AGAINST CANINE CTLA-4

      
Application Number 19322399
Status Pending
Filing Date 2025-09-08
First Publication Date 2026-05-07
Owner INTERVET INC. (USA)
Inventor
  • Morsey, Mohamad
  • Zhang, Yuanzheng
  • Tarpey, Ian

Abstract

The present invention provides caninized murine antibodies against canine CTLA-4 that have specific sequences and a high binding affinity for canine CTLA-4. The present invention further provides epitopes of canine CTLA-4 for caninized murine antibodies against canine CTLA-4. The invention also relates to use of these antibodies in the treatment of cancer in canines and other companion animals.

IPC Classes  ?

  • C07K 16/28 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
  • A61K 39/00 - Medicinal preparations containing antigens or antibodies
  • A61P 31/00 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
  • A61P 35/00 - Antineoplastic agents

89.

Miscellaneous Design

      
Serial Number 99784551
Status Pending
Filing Date 2026-04-24
Owner Merck Sharp & Dohme B.V. (Netherlands)
NICE Classes  ? 05 - Pharmaceutical, veterinary and sanitary products

Goods & Services

Pharmaceutical preparations for the treatment and prevention of bone, cardiovascular, central nervous system, dermatological, endocrine, hematological, hepatological, immunological, gastrointestinal, genitourinary, gynecological, metabolic, musculoskeletal, nephrological, neurological, oncological, ophthalmic, retinal, psychiatric, pulmonary, renal, respiratory, and urological diseases and disorde; Pharmaceutical preparations for the treatment and prevention of autoimmune diseases, asthma, cancer and tumors, chronic cough, diabetes, hypertension, insomnia, intestinal infections, skin disorders, and urinary incontinence; Inhalers filled with pharmaceutical preparations for the treatment of cardiovascular diseases and disorders; Antibacterial pharmaceuticals; Antibiotics; Antifungal preparations; Anti-infectives; Anti-inflammatories; Antiparasitics; Antivirals; Human vaccine preparations

90.

WYNIKTO

      
Serial Number 99784673
Status Pending
Filing Date 2026-04-24
Owner Merck Sharp & Dohme B.V. (Netherlands)
NICE Classes  ? 05 - Pharmaceutical, veterinary and sanitary products

Goods & Services

Pharmaceutical preparations for the treatment and prevention of bone, cardiovascular, central nervous system, dermatological, endocrine, hematological, hepatological, immunological, gastrointestinal, genitourinary, gynecological, metabolic, musculoskeletal, nephrological, neurological, oncological, ophthalmic, retinal, psychiatric, pulmonary, renal, respiratory, and urological diseases and disorders; Pharmaceutical preparations for the treatment and prevention of autoimmune diseases, asthma, cancer and tumors, chronic cough, diabetes, hypertension, insomnia, intestinal infections, skin disorders, and urinary incontinence; Inhalers filled with pharmaceutical preparations for the treatment of cardiovascular diseases and disorders; Antibacterial pharmaceuticals; Antibiotics; Antifungal preparations; Anti-infectives; Anti-inflammatories; Antiparasitics; Antivirals; Human vaccine preparations

91.

WYNTORFI

      
Serial Number 99784679
Status Pending
Filing Date 2026-04-24
Owner Merck Sharp & Dohme B.V. (Netherlands)
NICE Classes  ? 05 - Pharmaceutical, veterinary and sanitary products

Goods & Services

Pharmaceutical preparations for the treatment and prevention of bone, cardiovascular, central nervous system, dermatological, endocrine, hematological, hepatological, immunological, gastrointestinal, genitourinary, gynecological, metabolic, musculoskeletal, nephrological, neurological, oncological, ophthalmic, retinal, psychiatric, pulmonary, renal, respiratory, and urological diseases and disorders; Pharmaceutical preparations for the treatment and prevention of autoimmune diseases, asthma, cancer and tumors, chronic cough, diabetes, hypertension, insomnia, intestinal infections, skin disorders, and urinary incontinence; Inhalers filled with pharmaceutical preparations for the treatment of cardiovascular diseases and disorders; Antibacterial pharmaceuticals; Antibiotics; Antifungal preparations; Anti-infectives; Anti-inflammatories; Antiparasitics; Antivirals; Human vaccine preparations

92.

ADANVYZ

      
Serial Number 99784619
Status Pending
Filing Date 2026-04-24
Owner Merck Sharp & Dohme B.V. (Netherlands)
NICE Classes  ? 05 - Pharmaceutical, veterinary and sanitary products

Goods & Services

Pharmaceutical preparations for the treatment and prevention of bone, cardiovascular, central nervous system, dermatological, endocrine, hematological, hepatological, immunological, gastrointestinal, genitourinary, gynecological, metabolic, musculoskeletal, nephrological, neurological, oncological, ophthalmic, retinal, psychiatric, pulmonary, renal, respiratory, and urological diseases and disorders; Pharmaceutical preparations for the treatment and prevention of autoimmune diseases, asthma, cancer and tumors, chronic cough, diabetes, hypertension, insomnia, intestinal infections, skin disorders, and urinary incontinence; Inhalers filled with pharmaceutical preparations for the treatment of cardiovascular diseases and disorders; Antibacterial pharmaceuticals; Antibiotics; Antifungal preparations; Anti-infectives; Anti-inflammatories; Antiparasitics; Antivirals; Human vaccine preparations

93.

EYWINTIZ

      
Serial Number 99784635
Status Pending
Filing Date 2026-04-24
Owner Merck Sharp & Dohme B.V. (Netherlands)
NICE Classes  ? 05 - Pharmaceutical, veterinary and sanitary products

Goods & Services

Pharmaceutical preparations for the treatment and prevention of bone, cardiovascular, central nervous system, dermatological, endocrine, hematological, hepatological, immunological, gastrointestinal, genitourinary, gynecological, metabolic, musculoskeletal, nephrological, neurological, oncological, ophthalmic, retinal, psychiatric, pulmonary, renal, respiratory, and urological diseases and disorders; Pharmaceutical preparations for the treatment and prevention of autoimmune diseases, asthma, cancer and tumors, chronic cough, diabetes, hypertension, insomnia, intestinal infections, skin disorders, and urinary incontinence; Inhalers filled with pharmaceutical preparations for the treatment of cardiovascular diseases and disorders; Antibacterial pharmaceuticals; Antibiotics; Antifungal preparations; Anti-infectives; Anti-inflammatories; Antiparasitics; Antivirals; Human vaccine preparations

94.

KOWYNTO

      
Serial Number 99784638
Status Pending
Filing Date 2026-04-24
Owner Merck Sharp & Dohme B.V. (Netherlands)
NICE Classes  ? 05 - Pharmaceutical, veterinary and sanitary products

Goods & Services

Pharmaceutical preparations for the treatment and prevention of bone, cardiovascular, central nervous system, dermatological, endocrine, hematological, hepatological, immunological, gastrointestinal, genitourinary, gynecological, metabolic, musculoskeletal, nephrological, neurological, oncological, ophthalmic, retinal, psychiatric, pulmonary, renal, respiratory, and urological diseases and disorders; Pharmaceutical preparations for the treatment and prevention of autoimmune diseases, asthma, cancer and tumors, chronic cough, diabetes, hypertension, insomnia, intestinal infections, skin disorders, and urinary incontinence; Inhalers filled with pharmaceutical preparations for the treatment of cardiovascular diseases and disorders; Antibacterial pharmaceuticals; Antibiotics; Antifungal preparations; Anti-infectives; Anti-inflammatories; Antiparasitics; Antivirals; Human vaccine preparations

95.

APVIMRET

      
Serial Number 99784622
Status Pending
Filing Date 2026-04-24
Owner Merck Sharp & Dohme B.V. (Netherlands)
NICE Classes  ? 05 - Pharmaceutical, veterinary and sanitary products

Goods & Services

Pharmaceutical preparations for the treatment and prevention of bone, cardiovascular, central nervous system, dermatological, endocrine, hematological, hepatological, immunological, gastrointestinal, genitourinary, gynecological, metabolic, musculoskeletal, nephrological, neurological, oncological, ophthalmic, retinal, psychiatric, pulmonary, renal, respiratory, and urological diseases and disorders; Pharmaceutical preparations for the treatment and prevention of autoimmune diseases, asthma, cancer and tumors, chronic cough, diabetes, hypertension, insomnia, intestinal infections, skin disorders, and urinary incontinence; Inhalers filled with pharmaceutical preparations for the treatment of cardiovascular diseases and disorders; Antibacterial pharmaceuticals; Antibiotics; Antifungal preparations; Anti-infectives; Anti-inflammatories; Antiparasitics; Antivirals; Human vaccine preparations

96.

AWNTAY

      
Serial Number 99784628
Status Pending
Filing Date 2026-04-24
Owner Merck Sharp & Dohme B.V. (Netherlands)
NICE Classes  ? 05 - Pharmaceutical, veterinary and sanitary products

Goods & Services

Pharmaceutical preparations for the treatment and prevention of bone, cardiovascular, central nervous system, dermatological, endocrine, hematological, hepatological, immunological, gastrointestinal, genitourinary, gynecological, metabolic, musculoskeletal, nephrological, neurological, oncological, ophthalmic, retinal, psychiatric, pulmonary, renal, respiratory, and urological diseases and disorders; Pharmaceutical preparations for the treatment and prevention of autoimmune diseases, asthma, cancer and tumors, chronic cough, diabetes, hypertension, insomnia, intestinal infections, skin disorders, and urinary incontinence; Inhalers filled with pharmaceutical preparations for the treatment of cardiovascular diseases and disorders; Antibacterial pharmaceuticals; Antibiotics; Antifungal preparations; Anti-infectives; Anti-inflammatories; Antiparasitics; Antivirals; Human vaccine preparations

97.

RETTYLVI

      
Serial Number 99784652
Status Pending
Filing Date 2026-04-24
Owner Merck Sharp & Dohme B.V. (Netherlands)
NICE Classes  ? 05 - Pharmaceutical, veterinary and sanitary products

Goods & Services

Pharmaceutical preparations for the treatment and prevention of bone, cardiovascular, central nervous system, dermatological, endocrine, hematological, hepatological, immunological, gastrointestinal, genitourinary, gynecological, metabolic, musculoskeletal, nephrological, neurological, oncological, ophthalmic, retinal, psychiatric, pulmonary, renal, respiratory, and urological diseases and disorders; Pharmaceutical preparations for the treatment and prevention of autoimmune diseases, asthma, cancer and tumors, chronic cough, diabetes, hypertension, insomnia, intestinal infections, skin disorders, and urinary incontinence; Inhalers filled with pharmaceutical preparations for the treatment of cardiovascular diseases and disorders; Antibacterial pharmaceuticals; Antibiotics; Antifungal preparations; Anti-infectives; Anti-inflammatories; Antiparasitics; Antivirals; Human vaccine preparations

98.

RITVYVI

      
Serial Number 99784656
Status Pending
Filing Date 2026-04-24
Owner Merck Sharp & Dohme B.V. (Netherlands)
NICE Classes  ? 05 - Pharmaceutical, veterinary and sanitary products

Goods & Services

Pharmaceutical preparations for the treatment and prevention of bone, cardiovascular, central nervous system, dermatological, endocrine, hematological, hepatological, immunological, gastrointestinal, genitourinary, gynecological, metabolic, musculoskeletal, nephrological, neurological, oncological, ophthalmic, retinal, psychiatric, pulmonary, renal, respiratory, and urological diseases and disorders; Pharmaceutical preparations for the treatment and prevention of autoimmune diseases, asthma, cancer and tumors, chronic cough, diabetes, hypertension, insomnia, intestinal infections, skin disorders, and urinary incontinence; Inhalers filled with pharmaceutical preparations for the treatment of cardiovascular diseases and disorders; Antibacterial pharmaceuticals; Antibiotics; Antifungal preparations; Anti-infectives; Anti-inflammatories; Antiparasitics; Antivirals; Human vaccine preparations

99.

OCWINTLA

      
Serial Number 99784640
Status Pending
Filing Date 2026-04-24
Owner Merck Sharp & Dohme B.V. (Netherlands)
NICE Classes  ? 05 - Pharmaceutical, veterinary and sanitary products

Goods & Services

Pharmaceutical preparations for the treatment and prevention of bone, cardiovascular, central nervous system, dermatological, endocrine, hematological, hepatological, immunological, gastrointestinal, genitourinary, gynecological, metabolic, musculoskeletal, nephrological, neurological, oncological, ophthalmic, retinal, psychiatric, pulmonary, renal, respiratory, and urological diseases and disorders; Pharmaceutical preparations for the treatment and prevention of autoimmune diseases, asthma, cancer and tumors, chronic cough, diabetes, hypertension, insomnia, intestinal infections, skin disorders, and urinary incontinence; Inhalers filled with pharmaceutical preparations for the treatment of cardiovascular diseases and disorders; Antibacterial pharmaceuticals; Antibiotics; Antifungal preparations; Anti-infectives; Anti-inflammatories; Antiparasitics; Antivirals; Human vaccine preparations

100.

OWNTRI

      
Serial Number 99784649
Status Pending
Filing Date 2026-04-24
Owner Merck Sharp & Dohme B.V. (Netherlands)
NICE Classes  ? 05 - Pharmaceutical, veterinary and sanitary products

Goods & Services

Pharmaceutical preparations for the treatment and prevention of bone, cardiovascular, central nervous system, dermatological, endocrine, hematological, hepatological, immunological, gastrointestinal, genitourinary, gynecological, metabolic, musculoskeletal, nephrological, neurological, oncological, ophthalmic, retinal, psychiatric, pulmonary, renal, respiratory, and urological diseases and disorders; Pharmaceutical preparations for the treatment and prevention of autoimmune diseases, asthma, cancer and tumors, chronic cough, diabetes, hypertension, insomnia, intestinal infections, skin disorders, and urinary incontinence; Inhalers filled with pharmaceutical preparations for the treatment of cardiovascular diseases and disorders; Antibacterial pharmaceuticals; Antibiotics; Antifungal preparations; Anti-infectives; Anti-inflammatories; Antiparasitics; Antivirals; Human vaccine preparations
  1     2     3     ...     63        Next Page